Table 1 Baseline clinical characteristics of study patients with and without MVAEs
Non-MVAE group (n = 173) | MVAE group (n = 112) | p value | |
|---|---|---|---|
Age, years | 57.23 ± 15.9 | 57.87 ± 13.2 | 0.7148 |
Male sex, n (%) | 127(73.4%) | 93(83%) | 0.0806 |
Symptom-to-balloon time, hours | 2.79 ± 1.79 | 2.35 ± 1.42 | 0.0285 |
Hypertension, n (%) | 79(45.7%) | 58(51.8%) | 0.3741 |
Diabetes mellitus, n (%) | 75(43.4%) | 49(43.7%) | 0.9552 |
Smoker, n (%) | 70(40.5%) | 47(42%) | 0.8978 |
Left ventricular ejection fraction (%) | 57.72 ± 11.6 | 58.29 ± 12.15 | 0.176 |
Left ventricular end diastolic diameter (mm) | 46.79 ± 18.5 | 46.31 ± 19.6 | 0.3735 |
Blood potassium concentration at admission (mmol/L) | 4.04 ± 0.34 | 4.01 ± 0.38 | 0.266 |
Infarct-related artery | |||
Left anterior descending artery, n (%) | 51 | 41 | |
Right coronary artery, n (%) | 96 | 53 | 0.0867 |
Left circumflex artery, n (%) | 23 | 11 | |
Left main artery, n (%) | 3 | 7 | |
STE max (mV) | 3.38 ± 1.27 | 6.62 ± 2.84 | p < 0.0001 |